Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.22.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Restricted cash $ 46,430 $ 42,854
Notes receivable, net 453,617 446,322
Receivable backed notes payable - non-recourse $ 323,043 $ 340,154
Preferred stock, par value $ 0.01 $ 0.01
Preferred stock, shares authorized 10,000,000 10,000,000
Variable Interest Entity, Primary Beneficiary [Member]    
Restricted cash $ 16,238 $ 15,956
Notes receivable, net 241,460 248,873
Receivable backed notes payable - non-recourse $ 323,043 $ 340,154
Class A Common Stock [Member]    
Common Stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 30,000,000 30,000,000
Common stock, shares issued 16,967,261 17,118,392
Common stock, shares outstanding 16,967,261 17,118,392
Class B Common Stock [Member]    
Common Stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 4,000,000 4,000,000
Common stock, shares issued 3,664,311 3,664,412
Common stock, shares outstanding 3,664,311 3,664,412